Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a new page version. This update reflects maintenance rather than changes to the study information presented on the page.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedA revision/version label at the bottom of the page was updated from v3.5.2 to v3.5.3. This represents a change in the site’s release version rather than any modification to the clinical study details.SummaryDifference0.1%

- Check44 days agoChange DetectedFooter revision tag updated to v3.5.2, replacing the previous v3.5.0.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now displays a new revision note, v3.5.0, and the previous revision note, v3.4.3, was removed.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check109 days agoChange DetectedAdded Revision: v3.4.2 tag; removed the prior funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.